Group One Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Group One Trading’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-251,400	Closed	-$269K	–	8838
2022 Q1	$269K	Buy	251,400 +249,300	+11,871%	+$453K	﹤0.01%	4486
2021 Q4	$4K	Sell	2,100 -16,800	-89%	-$40.2K	﹤0.01%	7749
2021 Q3	$57K	Sell	18,900 -2,000	-10%	-$7.12K	﹤0.01%	6453
2021 Q2	$82K	Sell	20,900 -15,200	-42%	-$63K	﹤0.01%	6157
2021 Q1	$183K	Buy	36,100 +29,700	+464%	+$154K	﹤0.01%	5114
2020 Q4	$26K	Buy	6,400 +3,900	+156%	+$19.2K	﹤0.01%	5385
2020 Q3	$12K	Sell	2,500 -2,400	-49%	-$13.1K	﹤0.01%	5361
2020 Q2	$27K	Sell	4,900 -2,000	-29%	-$9.16K	﹤0.01%	4696
2020 Q1	$23K	Buy	+6,900	New	+$36.4K	﹤0.01%	4168

Group One Trading's AGTC Position: Q4 2022 in Review

Group One Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 4,080 shares — an estimated $1K sold.

Group One Trading first reported a position in AGTC in Q2 2020 and held it in 10 quarters. The position peaked at $372K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Group One Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Group One Trading sold 4,080 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $1K.
Group One Trading first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 10 quarters.
Group One Trading's Applied Genetic Technologies Corporation position peaked at $372K in Q1 2021.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.